1-(2-氧代吡咯烷-1-基)丁烷-1,3-二酮 | 53544-25-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 中文名称: 1-(2-氧代吡咯烷-1-基)丁烷-1,3-二酮
• 中文别名: 1,3-丁二酮,1-(2-氧代-1-吡咯烷基)-
• 英文名称: 1-(2-oxopyrrolidin-1-yl)butane-1,3-dione
• CAS: 53544-25-5
• 化学式: C₈H₁₁NO₃
• mdl: MFCD18801024
• 分子量: 169.18
• InChiKey: QNXHIIPZNDHXHS-UHFFFAOYSA-N

物化性质

• 熔点：
  49-52℃
• 密度：
  1.228

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.625
• 拓扑面积：
  54.4
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 海关编码：
  2933790090

反应信息

• 作为反应物：
  描述：

  1-(2-氧代吡咯烷-1-基)丁烷-1,3-二酮 在 dirhodium tetraacetate 三乙胺 、 甲烷磺酰基叠氮化物 作用下， 以 乙腈 、 苯 为溶剂， 反应 3.0h， 生成 dimethyl 2-acetyl-5-(3-isocyanatopropyl)furan-3,4-dicarboxylate
  参考文献：
  名称：

  Synthesis of nitrogen-containing polycycles via rhodium(II)-induced cyclization-cycloaddition and insertion reactions of N-(diazoacetoacetyl)amides. Conformational control of reaction selectivity

  摘要：

  A series of diazoacetoacetamides, when treated with a catalytic quantity of a rhodium(II) carboxylate, were found to afford products derived from both a carbonyl ylide intermediate and intramolecular C-H insertion. With 3-(N-(diazoacetoacetyl)amino)propanoate derivatives, the rhodium(II)-catalyzed carbenoid reactions exhibit a strong preference for formation of a beta-lactam ring. This is attributed to a conformational preference that juxtaposes the carbenoid center and the less sterically encumbered amide substituent and is consistent with an activating influence on the C-H bond adjacent to the amide nitrogen atom. Carbonyl ylide products derived from carbenoid cyclization onto the ester carbonyl group are also formed, and their relative yields are dependent on electronic influences from the bridging ligands of rhodium(II). Treatment of a series of cyclic diazoimides with rhodium(II) acetate resulted in cyclization of the rhodium carbenoid onto the adjacent imide carbonyl group to produce an isomunchnone dipole. Cyclization onto the imide carbonyl group occurs exclusively even when C-H insertion or aromatic substitution reactions of the carbenoid intermediate are favorable, and this selectivity is also attributed to conformational preferences that juxtapose the carbenoid center and imide carbonyl group. The isomunchnone dipole readily undergoes cycloaddition with several different dipolarophiles to give 1,3-dipolar cycloadducts. When acetylenic dipolarophiles were used as the trapping agents, the initial cycloadducts were found to undergo a [4 + 2]-cycloreversion, producing substituted furans in high yield. The generality of the method was demonstrated by varying the ring size of the cyclic imide. An analogous cyclization-cycloaddition reaction also occurred using diazoacetoacetyl-substituted ureas.

  DOI：

  10.1021/jo00002a058
• 作为产物：
  描述：

  2-吡咯烷酮 、 2,2,6-三甲基-4H-1,3-二英-4-酮 以 xylene 为溶剂， 反应 1.5h， 以94%的产率得到1-(2-氧代吡咯烷-1-基)丁烷-1,3-二酮
  参考文献：
  名称：

  铑（II）衍生的异麦草酮的双分子环加成反应重氮吡咯烷酮的环化反应

  摘要：

  在回流的苯中用催化量的乙酸铑（II）处理重氮取代的吡咯烷酮，首先导致形成铑类胡萝卜素，然​​后将其环化到相邻的羰基氧上以生成异麦角酮环系统。随后的环加成反应越过所添加的双极性亲和剂的π键，可以高收率获得1,3-偶极环加合物。衍生自2-重氮乙酰基-2-吡咯烷酮的异麦角酮与富电子（二乙基乙烯酮乙缩醛）和缺电子（N-苯基马来酰亚胺，甲基乙烯基酮）的双极性亲和剂容易反应。区域化学结果完全符合FMO理论。通过半经验AMAC计算确定了异辛酮的前沿轨道系数。当使用乙炔双极性亲电子试剂作为捕集剂时，没有分离出预期的偶极环加合物，而是进行了4 + 2-环还原，从而获得了呋喃异氰酸酯。通过与甲醇反应，将异氰酸酯表征为其氨基甲酸酯衍生物。

  DOI：

  10.1016/s0040-4020(01)86338-9

文献信息

• Catalytic asymmetric [3+2] cycloaddition of isomünchnones with methyleneindolinones
  作者：Kaixuan Wang、Chaoran Xu、Xinyue Hu、Yuqiao Zhou、Lili Lin、Xiaoming Feng

  DOI：10.1039/d1cc03685h

  日期：——

  An efficient enantioselective [3+2] cycloaddition of isomünchnones with methyleneindolinones that are generated by an in situ intramolecular addition of the carbonyl group to rhodium carbenes is realized with a chiral N,N′-dioxide/Zn(II) complex as a Lewis acid. A series of chiral oxa-bridged 3-spiropiperidines are obtained in high yields with excellent dr and excellent ee values.

  使用手性N , N '-二氧化物/Zn( II ) 络合物作为路易斯酸，通过将羰基原位分子内加成到卡宾铑上，实现了异明酮与亚甲基吲哚酮的有效对映选择性 [3+2] 环加成反应. 以高产率获得了一系列手性氧杂桥联的 3-螺哌啶，具有优异的 dr 和优异的 ee 值。
• Organocatalytic Multicomponent Reactions of 1,3-Dicarbonyls for the Synthesis of Enantioenriched Heterocycles
  作者：Xavier Bugaut、Thierry Constantieux、Haiying Du、Yohan Dudognon、Maria Sanchez Duque、Sébastien Goudedranche、Damien Bonne、Jean Rodriguez

  DOI：10.1055/s-0035-1561490

  日期：——

  Perhydropyridines 5 Conclusion and Perspective In this feature article, a general perspective of the research program aimed towards the preparation of polycyclic heterocycles by the means of enantioselective organocatalytic multicomponent reactions is presented. Guidelines for reaction design, including the selection of substrates and organocatalysts are discussed. For all transformations, scope and limitations are

  ‡两位作者均为本研究做出了同等贡献。 抽象的 在这篇专题文章中，介绍了旨在通过对映选择性有机催化多组分反应制备多环杂环的研究计划的总体观点。讨论了反应设计指南，包括底物和有机催化剂的选择。对于所有转化，都提出了范围和局限性，以及后功能化以提供多样化的杂环支架。 1引言 2种I类产品：1,4,5,6-四氢吡啶 3种II类产品：1,2,3,4-四氢吡啶 4种III类产品：桥联过氢吡啶 5结论与展望 在这篇专题文章中，介绍了旨在通过对映选择性有机催化多组分反应制备多环杂环的研究计划的总体观点。讨论了反应设计指南，包括底物和有机催化剂的选择。对于所有转化，都提出了范围和局限性，以及后功能化以提供多样化的杂环支架。 1引言 2种I类产品：1,4,5,6-四氢吡啶 3种II类产品：1,2,3,4-四氢吡啶 4种III类产品：桥联过氢吡啶 5结论与展望
• o-Iodoxybenzoic Acid (IBX)–Iodine Mediated One-Pot Deacylative Sulfonylation of 1,3-Dicarbonyl Compounds: A Synthesis of β-Carbonyl Sulfones
  作者：Chutima Kuhakarn、Praewpan Katrun、Teerawat Songsichan、Darunee Soorukram、Manat Pohmakotr、Vichai Reutrakul

  DOI：10.1055/s-0036-1588900

  日期：——

  combination of o-iodoxybenzoic acid (IBX) and a catalytic amount of iodine is found to promote a facile one-pot deacylative sulfonylation reaction of 1,3-dicarbonyl compounds with sodium sulfinates to yield β-carbonyl sulfones. The present method provides the target products bearing a wide variety of functional groups in one step and in good yields. A combination of o-iodoxybenzoic acid (IBX) and a catalytic

  摘要 发现邻碘氧苯甲酸（IBX）和催化量的碘的组合可促进1,3-二羰基化合物与亚磺酸钠的简便的一锅脱酰基磺酰化反应，生成β-羰基砜。本发明的方法一步一步提供高产率的带有多种官能团的目标产物。 发现邻碘氧苯甲酸（IBX）和催化量的碘的组合可促进1,3-二羰基化合物与亚磺酸钠的简便的一锅脱酰基磺酰化反应，生成β-羰基砜。本发明的方法一步一步提供高产率的带有多种官能团的目标产物。
• Compounds and methods for treating tumors, cancer and hyperproliferative diseases
  申请人：Yale University

  公开号：US07304092B1

  公开（公告）日：2007-12-04

  The present invention relates to novel compounds, pharmaceutical compositions and methods for treating tumors, cancer and hyperproliferative diseases including psoriasis, genital warts and hyperproliferative cell growth diseases, including hyperproliferative keratinocyte diseases such as hyperkeratosis, ichthyosis, keratoderma or lichen planus. These compounds are described according to the chemical structure: where R1 is H, OH, F, Cl, Br, I, a C1-C6 optionally substituted alkyl or alkenyl group, an optionally substituted aryl group or a  group; Ra is a H, OH, C1-C10, optionally substituted alkyl or alkenyl group, an optionally substituted O—(C1-C7 alkyl group) or O-aryl group, an amine group which is optionally substituted with at least one C1-C10 alkyl group which may be optionally substituted, or a single optionally substituted aryl group, biphenyl group, (C1-C6) alkylenearyl group, (C1-C6) alkylenebiphenyl group, heteroaryl group, heterocyclic group, (C1-C6) alkylene heteroaryl group or (C1-C6) alkylene heterocyclic group; R2 is a  group; Rb is a H, OH, C1-C10, optionally substituted alkyl or alkenyl group, an optionally substituted O—(C1-C7 alkyl group) or O-aryl group, an amine group which is optionally substituted with at least one C1-C10 alkyl group which may be optionally substituted, or a single optionally substituted aryl group, biphenyl group, (C1-C6) alkylenearyl group, (C1-C6) alkylenebiphenyl group, heteroaryl group, heterocyclic group, (C1-C6) alkylene heteroaryl group or (C1-C6) alkylene heterocyclic group; R3 and R6 are each independently selected from H, OH, F, Cl, Br, I, a C1-C6 optionally substituted alkyl or alkenyl group, an optionally substituted aryl group, a carbamate, alkylene carbamate, urethane or alkylene urethane; R4 is a  group, wherein Rb is as described above; and R5 is a  group, wherein Rb is as described above, with the proviso that at least one of R1 and R2 or R4 and R5 contains an Ra or Rb group which is an amine group which is optionally substituted with at least one C1-C10 alkyl group which may be optionally substituted, or a single optionally substituted aryl group, biphenyl group, (C1-C6) alkylenearyl group, (C1-C6) alkylenebiphenyl group, heteroaryl group, heterocyclic group, (C1-C6) alkylene heteroaryl group or (C1-C6) alkylene heterocyclic group; or a stereoisomer, pharmaceutically acceptable salt, solvate, and polymorph thereof.

  本发明涉及新化合物、药物组合物和治疗肿瘤、癌症和高增殖性疾病的方法，包括银屑病、生殖器疣和高增殖性细胞生长疾病，包括高增殖性角质细胞疾病，如角化症、鱼鳞病、角皮病或扁平苔藓病。这些化合物根据其化学结构描述如下：其中R1为H、OH、F、Cl、Br、I、C1-C6可选择取代的烷基或烯基基团、可选择取代的芳基团或a 基团；Ra为H、OH、C1-C10、可选择取代的烷基或烯基基团、可选择取代的O—(C1-C7烷基基团)或O-芳基团、可选择取代的胺基团，该胺基团可选择取代至少一个C1-C10烷基基团，该基团可选择取代，或者单一可选择取代的芳基团、联苯基团、(C1-C6)烷基芳基团、(C1-C6)烷基联苯基团、杂环芳基团、杂环基团、(C1-C6)烷基杂环芳基团或(C1-C6)烷基杂环基团；R2为a 基团；Rb为H、OH、C1-C10、可选择取代的烷基或烯基基团、可选择取代的O—(C1-C7烷基基团)或O-芳基团、可选择取代的胺基团，该胺基团可选择取代至少一个C1-C10烷基基团，该基团可选择取代，或者单一可选择取代的芳基团、联苯基团、(C1-C6)烷基芳基团、(C1-C6)烷基联苯基团、杂环芳基团、杂环基团、(C1-C6)烷基杂环芳基团或(C1-C6)烷基杂环基团；R3和R6各自独立地选择自H、OH、F、Cl、Br、I、C1-C6可选择取代的烷基或烯基基团、可选择取代的芳基团、碳酸酯、烷基碳酸酯、脲或烷基脲；R4为a 基团，其中Rb如上所述；和R5为a 基团，其中Rb如上所述，但至少其中之一的R1和R2或R4和R5含有Ra或Rb基团，该基团为可选择取代的胺基团，该胺基团可选择取代至少一个C1-C10烷基基团，该基团可选择取代，或者单一可选择取代的芳基团、联苯基团、(C1-C6)烷基芳基团、(C1-C6)烷基联苯基团、杂环芳基团、杂环基团、(C1-C6)烷基杂环芳基团或(C1-C6)烷基杂环基团；或其立体异构体、药用可接受的盐、溶剂化合物和多晶形式。
• Further reactions of t-butyl 3-oxobutanthioate and t-butyl 4-diethyl-phosphono-3-oxobutanthioate : Carbonyl coupling reactions, amination, use in the preparation of 3-acyltetramic acids and application to the total synthesis of fuligorubin A.
  作者：Steven V. Ley、Stephen C. Smith、Peter R. Woodward

  DOI：10.1016/s0040-4020(01)88210-7

  日期：1992.1

  for the preparation of homologated derivatives suitable for amination in the presence of silver (I) trifluoroacetate to afford the corresponding β-ketoamides is discussed. In particular Wadsworth-Emmons coupling reactions of (2) with various carbonyl compounds gave good yields of E-substituted products. Many of the β-ketoamides were shown to be suitable precursors for 3-acyltetramic acids using a Dieckmann

  3-氧代丁氧硫醇叔丁酯（1）和4-二乙基氧代-3-氧杂丁硫醇叔丁酯（2）的制备适合于在三氟乙酸银（I）存在下进行胺化的同系化衍生物，得到相应的β讨论了β-酮酰胺。特别地，（2）与各种羰基化合物的Wadsworth-Emmons偶联反应给出了良好的E-取代产物收率。使用Dieckmann环化反应，以四正丁基氟化铵为环化碱，发现许多β-酮酰胺是3-酰基四酸的合适前体。这些新的反应应用于多烯3-酰基四酸富叶红素A的全合成。